BEND, Ore., April 17, 2018 -- EVIO Inc. (“EVIO” or “the Company”) (OTCQB:EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce the appointment of David Kane as its new chief financial officer.
Prior to joining EVIO, Kane served as the chief financial officer of several private, micro-cap and small-cap companies, including one of the largest cannabis cultivator and retailers with operations in Nevada and Arizona. Kane is also a certified public accountant.
In his role as chief financial officer, Kane will be responsible for overseeing all the financial operations of EVIO, including financial planning and analysis, internal controls, accounting and financial reporting. Kane will report directly to Chief Executive Officer William Waldrop and oversee the shared services organizations.
Waldrop, EVIO’s co-founder and CEO stated, “We are excited about David joining the EVIO team. His experience with multi-state growth companies, the cannabis industry, and the public markets provides a unique combination of experience and will help drive the future of EVIO. His experience with the cannabis industry will be especially relevant as EVIO executes its growth plan with purchasing and deploying new cannabis testing labs across North America.”
Kane stated, “EVIO is uniquely positioned to be a leader in cannabis testing. The team that EVIO has formed is impressive. I am excited to be part of a leading company on the forefront of the evolving cannabis industry. As our customers turn to EVIO, I am excited to provide our team the infrastructure they need to be a best-in-class testing laboratory.”
Kane has a degree from the University of California, Los Angeles, and lives in Henderson, Nevada, with his wife and two children.
Kane replaces Christian Carnell, EVIO’s interim CFO, who will remain with EVIO as a consultant and help facilitate a smooth transition.
“I want to thank Christian for his guidance and contributions for the past few years,” said Waldrop.
About EVIO, Inc.
EVIO, Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. EVIO is on track to operate 18 of its state-of-the-art testing facilities by 2018. The Company is based in Bend, Oregon.
For more information, visit www.eviolabs.com.
Safe Harbor Statement
Any statements in this press release that are not statements of historical fact maybe considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.
CONTACT INFORMATION
Company Contact:
EVIO Inc.
Bend, OR
www.EVIOlabs.com
888.544.EVIO
[email protected]
Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]


Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Same sparkle, different story: how lab-grown diamonds are transforming the market
Capital One Says AML Review Led to Closure of Trump Organization Accounts
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Japan Earthquake Disrupts Auto and Chip Supply Chains
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 



